Chemical Compound

Bosentan Related Compound C

CAS Registry Number 1097263-60-9
Back to search Request a Quote
Bosentan Related Compound C chemical structure
Primary Record

Bosentan Related Compound C

In stock
1,961 g
Purity
99.7 %
CAS
1097263-60-9

Compound Identifiers & Properties

CAS
1097263-60-9
PubChem CID
59509251
SMILES
CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCOC4=NC(=NC(=C4OC5=CC=CC=C5OC)NS(=O)(=O)C6=CC=C(C=C6)C(C)(C)C)C7=NC=CC=N7)OC8=CC=CC=C8OC
Canonical SMILES
COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCOc1nc(-c2ncccn2)nc(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)c1Oc1ccccc1OC

Names & Synonyms

  • Bosentan Related Compound C
  • Bosentan Dimer
  • Bosentan dimer
  • 1097263-60-9
  • Bosentan impurity C
  • Bosentan USP Rc C
  • Bosentan Dimer Impurity
  • RefChem:196695
  • E37Q2R85EY
  • UNII-E37Q2R85EY
  • SCHEMBL7795452
  • Bosentan related compound C [USP-RS]
  • Bosentan USP Related Compound C
  • C52H52N10O10S2
  • WJWCTRNSPLUHTB-UHFFFAOYSA-N
  • CS-M2105
  • 3477AH
  • MFCD25977342
  • AKOS037650294
  • IB64076
  • 4-tert-butyl-N-[6-[2-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxyethoxy]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide
  • CS-14587
  • BOSENTAN RELATED COMPOUND C (USP-RS)
  • C12557
  • Benzenesulfonamide, N,N'-[1,2-ethanediylbis[oxy[5-(2-methoxyphenoxy)[2,2'-bipyrimidine]-6,4-diyl]]]bis[4-(1,1-dimethylethyl)-
  • N,N'-((ethane-1,2-diylbis(oxy))bis(5-(2-methoxyphenoxy)-[2,2'-bipyrimidine]-6,4-diyl))bis(4-(tert-butyl)benzenesulfonamide)
  • 1,2-Bis((6-(4-(tert-butyl)phenylsulfonamido)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl)oxy)ethane
  • Benzenesulfonamide, N,N'-(1,2-ethanediylbis(oxy(5-(2-methoxyphenoxy)(2,2'-bipyrimidine)-6,4-diyl)))bis(4-(1,1-dimethylethyl)-
  • N,N'-(1,2-Ethanediylbis(oxy(5-(2-methoxyphenoxy)(2,2'-bipyrimidine)-6,4-diyl)))bis(4-(1,1-dimethylethyl)benzenesulfonamide)
  • N,N'-[1,2-Ethanediylbis[oxy[5-(2-methoxyphenoxy)[2,2'-bipyrimidine]-6,4-diyl]]]bis[4-(1,1-dimethylethyl)-benzenesulfonamide
  • 4-tert-butyl-N-[6-(2-{[6-(4-tert-butylbenzenesulfonamido)-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl]oxy}ethoxy)-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl]benzene-1-sulfonamide
  • 1,2-bis({6-[4-(tert-Butyl)phenylsulfonamido]-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl}oxy)ethane
  • 1,2-Bis({6-[4-(tert-butyl)phenylsulfonamido]-5-(2-methoxyphenoxy)-[2,2?-bipyrimidin]-4-yl}oxy)ethane
  • 1,2-BIS(6-[4-(TERT-BUTYL)PHENYLSULFONAMIDO]-5-(2-METHOXYPHENOXY)-[2,2'-BIPYRIMIDIN]-4-YL OXY)ETHANE
  • 4-tert-butyl-N-[6-[2-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]oxyethoxy]-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]benzenesulfonamide
  • Benzenesulfonamide, N,N'-[1,2-ethanediylbis[oxy[5-(2-methoxyphenoxy)[2,2'-bipyrimidine]-6,4-diyl]]]bis[4-(1,1-dimethylethyl)-; N,N'-[1,2-ethanediylbis[oxy[5-(2-methoxyphenoxy)[2,2'-bipyrimidine]-6,4-diyl]]]bis[4-(1,1-dimethylethyl)benzenesulfonamide]; (1,2-bis({6-[4-(tert-butyl)phenylsulfonamido]-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl}oxy)ethane); Bosentan Related Compound C
  • BenzenesulfonaMide,N,N'-[1,2-ethanediylbis[oxy[5-(2-Methoxyphenoxy)[2,2'-bipyriMidine]-6,4-diyl]]]bis[4-(1,1-diMethylethyl)-
  • Bosentan impurity C; Bosentan USP Related Compound C; 1,2-bis({6-[4-(tert-Butyl)phenylsulfonamido]-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl}oxy)ethane; N,N'-[1,2-ethanediylbis[oxy[5-(2-methoxyphenoxy)[2,2'-bipyrimidine]-6,4-diyl]]]bis[4-(1,1-dimethylethyl)benzenesulfonamide]
  • Bosentan Related Compound C (1,2-bis({6-[4-(tert-butyl)phenylsulfonamido]-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl}oxy)ethane)
  • N,N'-(6,6''-(ethane-1,2-diylbis(oxy))bis(5-(2-methoxyphenoxy)-[2,2'-bipyrimidine]-6,4-diyl))bis(4-(tert-butyl)benzenesulfonamide)
  • N,N'-[1,2-Ethanediylbis[oxy[5-(2-methoxyphenoxy)[2,2'-bipyrimidine]-6,4-diyl]]]bis[4-(1,1-dimethylethyl)benzenesulfonamide]